Download PDF
Thromb Haemost 1993; 69(03): 253-258
DOI: 10.1055/s-0038-1651590
Original Article
Fibrinolysis
Schattauer GmbH Stuttgart

Herpes Simplex Virus Decreases Endothelial Cell Plasminogen Activator Inhibitor

Robert A Bok
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
,
Harry S Jacob
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
,
Jozsef Balla
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
,
Margaret Juckett
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
,
Theresa Stelle
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
,
Marie A Shatos
1   Department of Surgery, University of Vermont College of Medicine, Burlington, VT, USA
,
Gregory M Vercellotti
The Department of Medicine, University of Minnesota, Minneapolis, MN, USA
› Author Affiliations
Further Information

Publication History

Received 24 June 1992

Accepted after revision 06 November 1992

Publication Date:
05 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Herpes simplex virus (HSV) infection is histopathologically associated with vascular injury, fibrinoid necrosis and inflammatory cell infiltrates. We have previously shown in vitro that HSV infection of human umbilical vein endothelial cells (HUVEC) promotes a procoagulant phenotype manifest by the induction of tissue factor, the loss of thrombomodulin, and an increase in platelet adhesion. In these studies we examined the effects of HSV infection on HUVEC plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (t-PA). HSV infection caused the loss of PAI-1 in the extracellular matrix (ECM) and that released into the supernatant of HUVEC. Both activity and antigen levels of the Serpin inhibitor are diminished as a result of HSV infection. The loss of inhibitor is not secondary to diminished vitronectin (Vn), the primary binding protein of PAI-1 in the ECM, but appears to be secondary to decreased synthesis at the RNA level. Tissue plasminogen activator (t-PA). synthesis is also decreased in endothelial HSV infection. PAI-1 loss may further promote a procoagulant phenotype in HSV infection in vivo.

 

  • References

  • 1 Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacob HS. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci 1988; 85: 8227-8230
    CrossrefPubMedGoogle Scholar
  • 2 Key NS, Vercellotti GM, Winkelmann JC, Moldow CF, Goodman JL, Esmon NL, Esmon CT, Jacob HS. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci 1990; 87: 7095-7099
    CrossrefPubMedGoogle Scholar
  • 3 Vercellotti GM. Proinflammatory and procoagulant effects of herpes simplex infection on human endothelium. Blood Cells 1990; 16: 209-216
    PubMedGoogle Scholar
  • 4 Visser RM, Jacob HS, Goodman JL, McCarthy JB, Furcht LT, Vercellotti GM. Granulocyte-mediated injury to Herpes simplex virus-infected human endothelium. Lab Invest 1989; 60: 296-304
    PubMedGoogle Scholar
  • 5 Lever WF. Schaumber-Lever GHistopathology of the Skin. Lippin-cott; Philadelphia, PA: 1983: 360-365
    Google Scholar
  • 6 McSorley J, Shapiro L, Brownstein MH, Hsu KC. Herpes simplex and Varicella zoster: comparative histopathology of 77 cases. Int J Dermatol 1974; 13: 69-75
    CrossrefPubMedGoogle Scholar
  • 7 Loskutoff DJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemostasis Thromb 1988; 9: 87-116
    PubMedGoogle Scholar
  • 8 Ny T, Sawdey M, Lawrence DA, Millan JL, Loskutoff DJ. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 1986; 83: 6776-6780
    CrossrefPubMedGoogle Scholar
  • 9 Pannekoek H, Veerman H, Lambers H, Diergaarde P, Grondahl-Hansen J, Verweij CL, Van Zonneveld AJ, Van Mourik JA. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J 1986; 5: 2539-2544
    PubMedGoogle Scholar
  • 10 Ginsberg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 1986; 78: 1673-1673
    CrossrefPubMedGoogle Scholar
  • 11 Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124
    PubMedGoogle Scholar
  • 12 Owensby DA, Morton PA, Wun TC, Schwartz AL. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. J Biol Chem 1991; 266: 4334-4340
    PubMedGoogle Scholar
  • 13 Podack ER, Muller-Eberhard HJ. Isolation of human S-Protein, an inhibitor of the membrane attack complex of complement. J Biol Chem 1979; 254: 9908-9914
    PubMedGoogle Scholar
  • 14 Preissner KT. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut 1989; 59: 419-431
    CrossrefPubMedGoogle Scholar
  • 15 Moldow CF, Jacob HS. Endothelial culture, neutrophil or enzymatic generation of free radicals: In vitro methods for the study of endothelial injury. Methods Enzymol 1984; 105: 378-385
    PubMedGoogle Scholar
  • 16 Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest 1987; 80: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 17 Kruithof EKO, Tran-Thang C, Gudinchet A, Hawert J, Nicoloso G, Benton C, Welti H, Bachmann F. Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors. Blood 1987; 69: 460
    CrossrefPubMedGoogle Scholar
  • 18 Shatos MA, Doherty JM, Stump DC, Thompson EA, Collen D. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor in human endothelial cell culture. J Biol Chem 1990; 265: 20443-20448
    PubMedGoogle Scholar
  • 19 Stump DC, Thienpont M, Collen D. Purification and characterization of a novel inhibitor of urokinases from human urine. J Biol Chem 1986; 261: 1267-1273
    PubMedGoogle Scholar
  • 20 Halvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemostas 1985; 54: 684-687
    PubMedGoogle Scholar
  • 21 Tomasini BR, Mosher DF. Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood 1988; 72: 903-912
    PubMedGoogle Scholar
  • 22 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
    CrossrefPubMedGoogle Scholar
  • 23 Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984; 137: 266-267
    CrossrefPubMedGoogle Scholar
  • 24 Correa-Ritter R, Mariash CN, Rosenberg ME. Loading and transfer control for Northern hybridization. BioTechniques 1992; 12: 154-158
    PubMedGoogle Scholar
  • 25 Kaner RJ, Iozzo RV, Ziaie Z, Kefalides NA. Inhibition of proteoglycan synthesis in human endothelial cells after infection with Herpes simplex virus type 1 in vitro. Am J Respir Cell Mol Biol 1990; 2: 423-431
    CrossrefPubMedGoogle Scholar
  • 26 Etingin OR, Silverstein RL, Friedman HM, Hajjar DP. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 1990; 61: 657-662
    CrossrefPubMedGoogle Scholar
  • 27 Silnutzer J, Barnes DW. A biologically active thrombin cleavage product of human serum spreading factor. Biochem Biophys Res Commun 1984; 118: 339-343
    CrossrefPubMedGoogle Scholar
  • 28 Ryan TJ, Lai L, Malik AB. Plasmin generation induces neutrophil aggregation: Dependence on the catalytic and lysine binding sites. J Cell Physiol 1992; 151: 255-261
    CrossrefPubMedGoogle Scholar
  • 29 Ehrlich HJ, Bebbink RK, Keijer L, Linders M, Preissner KT, Pannekoek H. Alteration of Serpin specificity by a protein cofactor. J Biol Chem 1990; 265: 13029-13035
    PubMedGoogle Scholar
  • 30 Visser MR, Vercellotti GM, McCarthy JB, Goodman JL, Herbst TJ, Furcht LT, Jacob HS. Herpes simplex virus inhibits endothelial cell attachment and migration to extracellular matrix proteins. Am J Pathol 1989; 134: 223-230
    PubMedGoogle Scholar
  • 31 Tomasini BR, Owen MC, Fenton JW, Mosher DF. Conformational lability of vitronectin: induction of an antigenic change by α-thrombin-Serpin complexes and by proteolytically modified thrombin. Biochemistry 1989; 28: 7617-7623
    CrossrefPubMedGoogle Scholar